Hepatitis B

Disease State Hub

FDA Alerts

FDA Alert

FDA Alert

FDA Approves Bulevirtide-gmod (Hepcludex) for Chronic Hepatitis Delta Virus Infection

06/01/2026

Ashton L. Stahl

FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.

06/01/2026

Research Summaries

FDA Alert

FDA Approves Bulevirtide-gmod (Hepcludex) for Chronic Hepatitis Delta Virus Infection

06/01/2026

Ashton L. Stahl

FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.

06/01/2026

Public Health

Public Health

ACIP Revises Hepatitis B Birth Dose Recommendation

12/05/2025

Anthony Calabro, MA

On Friday, the Advisory Committee on Immunization Practices voted 8-3 on major changes to the long-standing universal hepatitis B birth-dose policy, introducing shared decision-making for infants born to...

12/05/2025

Meeting Coverage

Meeting Coverage

What Clinicians Need to Know About ACIP’s September 2025 Meeting

10/23/2025

Miranda Manier, BA

From shifting COVID-19 vaccine recommendations to updates on hepatitis B and MMRV, ACIP’s latest votes have direct implications for clinical practice.

10/23/2025

Vaccine Recommendations

ACIP Releases 2023 Adult Immunization Schedule

02/13/2023

The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.

02/13/2023

hepatitis B

USPSTF Updates HBV Screening Recommendations

12/17/2020

The US Preventive Services Task Force has released new recommendations for Screening for hepatitis B virus (HBV) infection.

12/17/2020

June 2026

Current Issue

June 2026